Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 241

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 241
---
 to have, a materially adverse impact on the business, assets, liabilities, condition (financial or otherwise), financial position or results of operations of such Person and its Subsidiaries, taken as a whole, or the ability of such person or entity or any of its subsidiaries on a timely basis to consummate the transactions contemplated by the Merger Agreement or the ancillary documents to which it is a party or bound or to perform its obligations thereunder, in each case subject to certain customary exceptions. Certain of the representations are subject to specified exceptions and qualifications contained in the Merger Agreement or in information provided pursuant to certain confidential disclosure schedules exchanged by the parties in connection with the signing of the Merger Agreement. While NLS and Kadimastem do not believe that these disclosure schedules contain information required to be publicly disclosed under the applicable securities laws, other than information that has already been so disclosed, the disclosure schedules do contain information that modifies, qualifies and creates exceptions to the representations and warranties set forth in the Merger Agreement. Accordingly, you should not rely on the representations and warranties as current characterizations of factual information about NLS, Kadimastem or Merger Sub, because they were made as of specific dates, may be intended merely as a risk allocation mechanism between NLS and Merger Sub on the one hand, and Kadimastem on the other hand, and are modified by the disclosure schedules. The Merger Agreement contains customary representations and warranties of NLS, Merger Sub and Kadimastem for a transaction of this type relating to, among other things: •organizational and qualification; subsidiaries; investments; •capitalization; •authority relative to this agreement; recommendation; •Israeli securities filings; financial statements; •information supplied; •consents and approvals; no violations; •no default; •no undisclosed liabilities; absence of changes; •litigation; •compliance with applicable laws •environmental laws and regulations •taxes; •intellectual property; •insurance; •certain business practices; 114 •tangible personal property; title; sufficiency of assets; •material contracts; •grants, incentives and subsidies; •affiliates; transactions with affiliates; •brokers; •employee benefits; •labor and employment matters; •indebtedness; •real property; •anti -takeoverstatutes; •no other representations; or •ownership of stock. No Survival No party’s representations, warranties or pre -Closingcovenants will survive the Closing, and no